InvestorsHub Logo

Pharma Sleuth

12/23/23 4:17 PM

#392522 RE: jour_trader #392521

Nah. You go back and show me the quotes that said they were going to shelve it for pricing. Especially since they can make it for the same price as the current ADT and in fact it's cheaper to make. That is what he actually said.

NASDAQ2020

12/23/23 7:13 PM

#392525 RE: jour_trader #392521

The two bead with naltrexone is expensive to make. If FDA decreases non ADF quota is only way it would work.
However Generic OxyContin, one bead tech are cheap to make.
Elite Unique ADT that was run along side of SequestOx has no naltrexone and it is 90% cheaper to produce.
Patents pending
🔨⏰
Bullish
Bullish